Promising New Targeted Agents in Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2 SUPPL., 2007, Pages

  Siu, Lillian L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AP 23573; AURORA A KINASE; AURORA B KINASE; AURORA KINASE INHIBITOR; AZD 0530; AZD 1152; BOSUTINIB; CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE; DASATINIB; ERLOTINIB; EVEROLIMUS; FOCAL ADHESION KINASE; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MLN 8054; MP 529; PF 00562271; PHA 739358; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; TEMSIROLIMUS; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL CYCLE ARREST; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; HEAD AND NECK CANCER; HUMAN; PRIORITY JOURNAL; SOLID TUMOR;

CARCINOMA, SQUAMOUS CELL; ENZYME INHIBITORS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEAD AND NECK NEOPLASMS; HUMANS; PROTEIN-SERINE-THREONINE KINASES; PYRIMIDINES; SIROLIMUS; SRC-FAMILY KINASES; THIAZOLES;

EID: 34548386714     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.037     Document Type: Article

References (9)

1. Siesser P.M., and Hanks S.K. The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12 (2006) 3233-3237
2. Johnson F.M., Saigal B., Talpaz M., et al. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 11 (2005) 6924-6932
3. Canel M., Secades P., Rodrigo J.P., et al. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of FAK gene copy number. Clin Cancer Res 12 (2006) 3272-3279
4. Schmelzle T., and Hall M.N. TOR, a central controller of cell growth. Cell 103 (2000) 253-262
5. Lee J.I., Soria J.C., Hassan K.A., et al. Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 127 (2001) 1441-1445
6. Massarelli E., Liu D.D., Lee J.J., et al. Akt activation correlates with adverse outcome in tongue cancer. Cancer 104 (2005) 2430-2436
7. Amornphimoltham P., Patel V., Sodhi A., et al. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res 65 (2005) 9953-9961
8. Warner S.L., Gray P.J., and Von Hoff D.D. Tubulin-associated drug targets: Aurora kinases, polo-like kinases, and others. Semin Oncol 33 (2006) 436-448
9. Reiter R., Gais P., Jutting U., et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 5136-5141